Category: Zacks Small Cap Research

123455230 / 514 POSTS
By Ann Heffron, CFA, CPAOTC:CPKFREAD THE FULL CPKF RESEARCH REPORTChesapeake Financial's (OTC:CPKF) first quarter net earnings rose $0.2 million, or 2%, year over year to $3.0 million, while 2019’s first quarter diluted EPS increased by $0.02, or 2%, ...
By M. MarinOTC:VQSLF | TSX:VQSREAD THE FULL VQSLF RESEARCH REPORTVIQ Solutions (OTC:VQSLF) (TSX:VQS) operates a secure technology platform that offers artificial intelligence (AI) enabled video capture software and audio recording with voice-to-text ...
By Brian Marckx, CFANASDAQ:MNKDREAD THE FULL MNKD RESEARCH REPORTNew data from three different studies of Afrezza was announced at the American Diabetes Association’s 79th Scientific Sessions (June 7 – 11) in San Francisco. This includes safety and P ...
By Lisa ThompsonNYSE:DSSREAD THE FULL DSS RESEARCH REPORTDocument Security Systems, Inc. (NYSE:DSS) has long been afflicted with not having enough resources to pursue growth and this past quarter the company took actions to address longer term needs ...
By David Bautz, PhDNASDAQ:BVXVREAD THE FULL BVXV RESEARCH REPORTFinancial UpdateOn May 30, 2019, BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) announced financial results for the first quarter of 2019. As expected, the company did not report any revenu ...
By John Vandermosten, CFANASDAQ:HTBXREAD THE FULL HTBX RESEARCH REPORTFirst Quarter 2019 Results Heat Biologics, Inc. (NASDAQ:HTBX) reported first quarter 2019 results in a May 15 release and concurrently submitted the companion 10-Q to the SEC. Sinc ...
By John Vandermosten, CFANASDAQ:ACHVAchieve Life Sciences, Inc. (NASDAQ:ACHV) reported topline results from its Phase IIb Ongoing Research of Cytisinicline for Addiction (ORCA)-1 trial which was launched in October 2018. The study enrolled 254 subjec ...
By John Vandermosten, CFAOTC:GOVXREAD THE FULL GOVX RESEARCH REPORTGeoVax Labs, Inc. (OTC:GOVX) filed its first quarter 2019 10-Q and issued the accompanying press release on May 14, 2019 providing an operational and financial update on the company’s ...
By John Vandermosten, CFAOTC:PREDREAD THE FULL PRED RESEARCH REPORTPredictive Technology Group, Inc. (OTC:PRED) is a cellular therapy and genetic diagnostic testing company currently commercializing its portfolio of four placental and Wharton’s Jelly ...
By John Vandermosten, CFANASDAQ:PHIOREAD THE FULL PHIO RESEARCH REPORTPhio Pharmaceuticals Corp. (NASDAQ:PHIO) reported first quarter 2019 results and filed its Form 10-Q on May 14, 2019. Since the beginning of the year, the company has announced a n ...
123455230 / 514 POSTS